journal cover

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

Arthritis and Rheumatism

Jul 27, 2006

W G DixonBritish Society for Rheumatology Biologics Register

Abstract

To determine whether the rate of serious infection is higher in anti-tumor necrosis factor (anti-TNF)-treated rheumatoid arthritis (RA) patients compared with RA patients treated with traditional disease-modifying antirheumatic drugs (DMARDs). This was a national prospective observation...read more

Mentioned in this Paper

Monoclonal Antibodies
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Humira
Biological Products
Tumor Necrosis Factor Receptor
Protoplasm
Incidence Studies
Immunocompromised Host
Rheumatoid Arthritis
1
191
1
Paper Details
References
  • References30
  • Citations328
123
  • References30
  • Citations328
12345...

Related Papers

Arthritis and Rheumatism

Infections in patients with rheumatoid arthritis treated with biologic agents

Arthritis and RheumatismOctober 29, 2005
Joachim ListingAngela Zink
© 2020 Meta ULC. All rights reserved

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

Arthritis and Rheumatism

Jul 27, 2006

W G DixonBritish Society for Rheumatology Biologics Register

PMID: 16868999

DOI: 10.1002/art.21978

Abstract

To determine whether the rate of serious infection is higher in anti-tumor necrosis factor (anti-TNF)-treated rheumatoid arthritis (RA) patients compared with RA patients treated with traditional disease-modifying antirheumatic drugs (DMARDs). This was a national prospective observation...read more

Mentioned in this Paper

Monoclonal Antibodies
Antirheumatic Drugs, Disease-Modifying
Tumor Necrosis Factor-alpha
Humira
Biological Products
Tumor Necrosis Factor Receptor
Protoplasm
Incidence Studies
Immunocompromised Host
Rheumatoid Arthritis
1
191
1

Related Papers

Arthritis and Rheumatism

Infections in patients with rheumatoid arthritis treated with biologic agents

Arthritis and RheumatismOctober 29, 2005
Joachim ListingAngela Zink
Paper Details
References
  • References30
  • Citations328
123
  • References30
  • Citations328
12345...
/papers/rates-of-serious-infection-including-site-specific/16868999